Telix Pharmaceuticals Limited (ASX:TLX)
Australia · Delayed Price · Currency is AUD 15.58
+0.09 (0.58%)
Aug 27, 2026, 4:10 PM AEST
Telix Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Telix Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $23.44. The average 1-year stock price forecast is 50.45% higher than the current stock price, while the lowest is $18.50 (+18.74%) and the highest is $31.00 (+98.97%).
Price Target: $23.44 (+50.45%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Telix Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 8 | 8 | 8 | 9 | 9 |
| Buy | 4 | 5 | 6 | 6 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 13 | 14 | 14 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Ord Minnett No rating | Ord Minnett | Buy Maintains $20.40 | Buy | Maintains | $20.40 | +30.94% | Aug 24, 2026 |
| Jarden | Jarden | Buy Maintains $21.10 → $20.70 | Buy | Maintains | $21.10 → $20.70 | +32.86% | Aug 22, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $23.90 | Buy | Maintains | $23.90 | +53.40% | Aug 21, 2026 |
| Jefferies | Jefferies | Buy Maintains $29.00 → $29.30 | Buy | Maintains | $29.00 → $29.30 | +88.06% | Aug 21, 2026 |
| Citi | Citi | Buy Maintains $31.00 | Buy | Maintains | $31.00 | +98.97% | Aug 20, 2026 |
Financial Forecast
Revenue This Year
919.81M
from 803.79M
Increased by 14.43%
Revenue Next Year
1.06B
from 919.81M
Increased by 15.04%
EPS This Year
0.04
from -0.02
EPS Next Year
-0.01
from 0.04
EPS and Forward PE are based on non-GAAP adjusted numbers.